Volume 18, Number 5—May 2012
Letter
High Anti–Phenolic Glycolipid-I IgM Titers and Hidden Leprosy Cases, Amazon Region
Table
Group | Household contact anti–PGL-I IgM ELISA result | No. households visited | No. persons examined | No. new cases |
||
---|---|---|---|---|---|---|
Among persons previously tested | Among contacts of persons previously tested | Total† | ||||
Leprosy patients | Positive | 14 | 43 | 9 | 4 | 13 |
Negative | 11 | 42 | 1 | 1 | 2 | |
Students | Positive | 11 | 84 | 5 | 5 | 10 |
Negative | 8 | 53 | 1 | 4 | 5 | |
Total | 44 | 222 | 16 | 14 | 30 |
*Households were selected from among 35 leprosy patients encountered during the first visit (25 households, 14 with an anti–PGL-I–positive contact in the household and 11 without) and among students with results of anti–PGL-I serology (19 households, 11 with an anti–PGL-I–positive contact in the household and 8 without). PGL-I, phenolic glycolipid-I.
†Fisher exact test comparing case-patients and non–case-patients among those positive or negative for anti-PGL-I IgM revealed a statistically significant difference (p = 0.0280).
Page created: April 06, 2012
Page updated: April 06, 2012
Page reviewed: April 06, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.